Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

46.51
Delayed Data
As of Dec 02
 -0.425 / -0.91%
Today’s Change
35.07
Today|||52-Week Range
54.96
+21.88%
Year-to-Date
3 Biotech Stocks to Buy in December
Dec 01 / MotleyFool.com - Paid Partner Content
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial
Nov 29 / Zacks.com - Paid Partner Content
Cytori Scleroderma Study Two-Year Follow-Up Data Published
Nov 30 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Chemours, Matador Resources, Best Buy, Anika Therapeut...
Nov 25 / Zacks.com - Paid Partner Content
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Nov 30 / Zacks.com - Paid Partner Content
Navidea Inks Deal to to Sell Lymphoseek to Cardinal Health
Nov 25 / Zacks.com - Paid Partner Content
Foamix Completes Enrolment in Phase III Acne Drug Studies
Nov 30 / Zacks.com - Paid Partner Content
OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S.
Nov 25 / Zacks.com - Paid Partner Content
Aimmune Closes Enrolment in Phase III Peanut Allergy Study
Nov 30 / Zacks.com - Paid Partner Content
Merck (MRK) Announces 2.2% Increase in Quarterly Dividend
Nov 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.94
Today’s open46.81
Day’s range46.37 - 47.10
Volume100,071
Average volume (3 months)117,920
Market cap$680.1M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)+3.81%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.93%
P/E ratio20.0
Price/Sales6.29
Price/Book3.32

Competitors

 Today’s
change
Today’s
% change
NVCRNovocure Ltd+0.55+7.38%
CRYCryoLife Inc-0.75-4.03%
ATRCAtriCure Inc+0.49+2.67%
ANGOAngioDynamics Inc+0.28+1.73%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts


Search for Jobs